Efficacy and safety of rituximab for systemic lupus erythematosus ‐associated immune cytopenias. A multicenter retrospective cohort study of 71 adults

In conclusion, RTX seems effective and relatively safe for treating SLE‐associated immune cytopenias. This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - December 17, 2017 Category: Hematology Authors: Alexandra Serris, Zahir Amoura, Florence Canou ï‐Poitrine, Benjamin Terrier, Eric Hachulla, Nathalie Costedoat‐Chalumeau, Thomas Papo, Olivier Lambotte, David Saadoun, Miguel Hié, Philippe Blanche, Bertrand Lioger, Jacques‐Eric Gottenberg, Bertran Tags: Research Article Source Type: research